Lee Hood’s Firm to Use Proteomics, Other Technologies to Develop Diagnostic Tools

The firm, called Integrated Diagnostics, will validate existing biomarkers and develop assays for them using MRM and proprietary technologies. It expects to launch its first test in about four years.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.